|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||19.52 - 19.92|
|52-week range||16.50 - 21.51|
|Beta (5Y monthly)||0.39|
|PE ratio (TTM)||16.57|
|Forward dividend & yield||1.10 (5.55%)|
|Ex-dividend date||18 Nov 2021|
|1y target est||N/A|
GSK earnings call for the period ending September 30, 2021.
Glaxo (GSK) beats earnings as well as revenues estimates in the third quarter of 2021. Stock up.
GlaxoSmithKline will add a leading scientist to its board and raised forecasts as Dame Emma Walmsley fends off activist investors who want to push her out of the job.